Stem cell therapy and diabetic erectile dysfunction: A critical review.

Area of Science:

• Endocrinology
• Regenerative Medicine
• Urology

Background:

• Erectile dysfunction (ED) is a frequent complication of diabetes mellitus (DM), affecting an estimated 67.4% of cases globally.
• Pathophysiology involves endothelial, neurological, hormonal, and psychological factors, with vascular and neural damage due to insulin resistance being key in diabetic ED.
• Current ED treatments like PDE5 inhibitors and surgery manage symptoms but do not address underlying causes.

Purpose of the Study:

• To review the current state of stem cell therapy for erectile dysfunction, particularly in the context of diabetes mellitus.
• To evaluate the potential of stem cells as a causal treatment for ED, moving beyond symptomatic relief.

Main Methods:

• Review of experimental studies, primarily in animal models, investigating stem cell therapy for ED.
• Analysis of stem cell sources (adipose, bone, urine) and their observed effects on erectile quality and tissue.

Main Results:

• Studies in experimental animals demonstrate improvements in erectile function and penile tissue following stem cell transplantation.
• Stem cells derived from various sources have shown efficacy in preclinical models of ED.

Conclusions:

• Stem cell therapy presents a promising therapeutic avenue for erectile dysfunction, particularly in diabetic patients.
• While human trials are limited, findings from animal models strongly suggest the potential of stem cells to treat the root causes of ED.